Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $51,606 | 14 | 92.1% |
| Travel and Lodging | $1,724 | 10 | 3.1% |
| Food and Beverage | $1,034 | 15 | 1.8% |
| Unspecified | $890.49 | 4 | 1.6% |
| Honoraria | $800.00 | 1 | 1.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,795 | 8 | $0 (2023) |
| Genentech, Inc. | $9,877 | 5 | $0 (2020) |
| GENZYME CORPORATION | $7,629 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $7,312 | 10 | $0 (2019) |
| Aimmune Therapeutics, Inc. | $5,720 | 9 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $4,053 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $3,825 | 1 | $0 (2021) |
| ALK-Abello, Inc | $2,800 | 2 | $0 (2022) |
| Kaleo, Inc. | $24.63 | 1 | $0 (2018) |
| SANOFI US SERVICES INC. | $19.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $352.29 | 2 | Novartis Pharmaceuticals Corporation ($352.29) |
| 2022 | $1,520 | 9 | ALK-Abello, Inc ($800.00) |
| 2021 | $21,525 | 7 | Novartis Pharmaceuticals Corporation ($9,538) |
| 2020 | $16,782 | 8 | Genentech, Inc. ($9,877) |
| 2019 | $8,203 | 14 | GlaxoSmithKline, LLC. ($7,312) |
| 2018 | $7,653 | 3 | GENZYME CORPORATION ($7,629) |
| 2017 | $19.34 | 1 | SANOFI US SERVICES INC. ($19.34) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $339.89 | General |
| 02/26/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.40 | General |
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Travel and Lodging | In-kind items and services | $331.15 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Travel and Lodging | In-kind items and services | $63.30 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $56.15 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $141.71 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $39.70 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ALLERGY | ||||||
| 02/25/2022 | ALK-Abello, Inc | — | Honoraria | Cash or cash equivalent | $800.00 | General |
| 07/14/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,825.00 | General |
| 06/01/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $4,087.50 | General |
| 05/17/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Consulting Fee | Cash or cash equivalent | $1,635.00 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Consulting Fee | Cash or cash equivalent | $1,635.00 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2021 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,162.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/08/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2021 | AIMMUNE THERAPEUTICS, INC. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 11/16/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2020 | Genentech, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Immunology | ||||||
| 08/31/2020 | NOVARTIS PHARMACEUTICALS CORPORATION | XOLAIR (Biological) | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2020 | ALK-Abello, Inc | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 01/25/2020 | Genentech, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $353.42 | General |
| Category: Immunology | ||||||
| 01/24/2020 | Genentech, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $6,380.00 | General |
| Category: Immunology | ||||||
| 01/24/2020 | Genentech, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $277.75 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy | Regeneron Pharmaceuticals, Inc. | $890.49 | 4 |
About Dr. Wayne Shreffler, M.D
Dr. Wayne Shreffler, M.D is a Pediatric Allergy/Immunology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174592448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Shreffler, M.D has received a total of $56,055 in payments from pharmaceutical and medical device companies, with $352.29 received in 2023. These payments were reported across 44 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($51,606).
Practice Information
- Specialty Pediatric Allergy/Immunology
- Location New York, NY
- Active Since 03/17/2006
- Last Updated 09/07/2012
- Taxonomy Code 2080P0201X
- Entity Type Individual
- NPI Number 1174592448
Products in Payments
- XOLAIR (Biological) $10,355
- Xolair (Biological) $9,877
- NO PRODUCT DISCUSSED (Drug) $7,648
- DUPIXENT (Biological) $4,053
- NUCALA (Biological) $812.18
- PALFORZIA (Biological) $720.26
- Auvi-Q (Drug) $24.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Allergy/Immunology Doctors in New York
Jordan Orange, M.d, M.D
Pediatric Allergy/Immunology — Payments: $263,101
Anna Nowak-Wegrzyn, M.d, M.D
Pediatric Allergy/Immunology — Payments: $96,534
Ramsay Fuleihan, Md, MD
Pediatric Allergy/Immunology — Payments: $79,833
Dr. Ama Alexis, M.d, M.D
Pediatric Allergy/Immunology — Payments: $77,915
Julie Wang, M.d, M.D
Pediatric Allergy/Immunology — Payments: $17,278
Hugh Sampson, M.d, M.D
Pediatric Allergy/Immunology — Payments: $9,850